In another retrospective series of ER+, HER2− breast cancer patients, integrating Ki-67 index into the American Joint Committee on Cancer (AJCC) 8th Edition’s prognostic staging system helped identify patients with good prognosis, for whom treatment de-escalation could be considered [12]. Here, ERBB2 is linked to breast carcinoma.